WASHINGTON, Nov. 13, 2012 /PRNewswire-USNewswire/ -- Seventy-two percent of Americans between the ages of 18 and 34 have either not heard about lupus at all or know little or nothing about the disease beyond the name, according to a new, independent survey released today by the Lupus Foundation of America. The statistic is particularly disturbing because this is the age group at the greatest risk for the disease.
YOU can help raise awareness:
Drug Combo Offers Long Term Benefits for SLE
WASHINGTON -- An 18-month treatment with the combination of rituximab and cyclophosphamide (Cytoxan) stopped progression of systemic lupus erythematosus (SLE) for at least 3 years.
The mean SLE Disease Activity Index (SLEDAI) score decreased from 8.929 to 1.917 after the first 6 months of therapy and remained low thereafter, reported Thomas Lehman, MD, from the Hospital for Special Surgery in New York City, and colleagues at the at American College of Rheumatology meeting.